GH1 and peripheral arterial disease: To see the importance of the decrease in plasma TNF-α by GH, it is worth highlighting a meta-analysis of 54 prospective cohort studies on inflammation and PAD, in which plasma TNF-α was able to predict the risk of CV events with the same magnitude as the therapies for lowering blood pressure or lipids [47,48].